{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:44Z","timestamp":1786119464965,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/mcp.0b013e328335df1e","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T01:06:35Z","timestamp":1264640795000},"page":"97-105","source":"Crossref","is-referenced-by-count":35,"title":["Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety"],"prefix":"10.1097","volume":"16","author":[{"given":"Donald P","family":"Tashkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210206","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0024-3205(98)00588-8","article-title":"Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease","volume":"64","author":"Disse","year":"1999","journal-title":"Life Sci"},{"key":"R2-4-20210206","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/thorax.58.10.855","article-title":"Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease","volume":"58","author":"Calverley","year":"2003","journal-title":"Thorax"},{"key":"R3-4-20210206","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thx.2006.063271","article-title":"Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis","volume":"61","author":"Barr","year":"2006","journal-title":"Thorax"},{"key":"R4-4-20210206","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000089655","article-title":"The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.","volume":"73","author":"Verkindre","year":"2006","journal-title":"Respiration"},{"key":"R5-4-20210206","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","article-title":"Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in patients with COPD","volume":"23","author":"O'Donnell","year":"2004","journal-title":"Eur Respir J"},{"key":"R6-4-20210206","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1378\/chest.128.3.1168","article-title":"Improvements in symptom-limited exercise performance over 8 hr with once-daily tiotropium in patients with COPD","volume":"128","author":"Maltais","year":"2005","journal-title":"Chest"},{"key":"R7-4-20210206","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1378\/chest.130.6.1695","article-title":"Pooled clinical trial analysis of tiotropium safety","volume":"130","author":"Kesten","year":"2006","journal-title":"Chest"},{"key":"R9-4-20210206","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1155\/2007\/192961","article-title":"A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease","volume":"14","author":"Chan","year":"2007","journal-title":"Can Respir J"},{"key":"R10-4-20210206","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pupt.2006.10.001","article-title":"Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study","volume":"21","author":"Bateman","year":"2008","journal-title":"Pulmon Pharmacol Therapeut"},{"key":"R11-4-20210206","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The salmeterol multicenter asthma research trial, a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol","volume":"126","author":"Nelson","year":"2006","journal-title":"Chest"},{"key":"R12-4-20210206","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/15412550701815981","article-title":"Efficacy of tiotropium inhalation powder in African-American patients with chronic obstructive pulmonary disease","volume":"5","author":"Criner","year":"2008","journal-title":"COPD: J COPD"},{"key":"R13-4-20210206","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.rmed.2007.08.003","article-title":"Improvements with tiotropium in COPD patients with concomitant asthma","volume":"102","author":"Magnusson","year":"2008","journal-title":"Respir Med"},{"key":"R14-4-20210206","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A four-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"R17-4-20210206","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pupt.2004.10.003","article-title":"One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium","volume":"18","author":"Anzueto","year":"2005","journal-title":"Pulm Pharmacol Therapeut"},{"key":"R19-4-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-143-5-200509060-00007","article-title":"Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator","volume":"143","author":"Niewoehner","year":"2005","journal-title":"Ann Intern Med"},{"key":"R20-4-20210206","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1183\/09031936.06.00062705","article-title":"The effect of tiotropium on exacerbations and airflow in patients with COPD","volume":"27","author":"Dusser","year":"2006","journal-title":"Eur Respir J"},{"key":"R21-4-20210206","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1183\/09031936.00023907","article-title":"Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD","volume":"30","author":"Powrie","year":"2007","journal-title":"Eur Respir J"},{"key":"R22-4-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","article-title":"The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol\/fluticasone propionate or tiotropium bromide","volume":"177","author":"Wedzicha","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-4-20210206","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/ajrccm.164.3.2002052","article-title":"Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction","volume":"164","author":"O'Brien","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-4-20210206","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"R25-4-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/rccm.200611-1630OC","article-title":"Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia","volume":"176","author":"Ernst","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-4-20210206","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2008.717","article-title":"Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"Drummond","year":"2008","journal-title":"J Am Med Assoc"},{"key":"R27-4-20210206","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones","year":"2002","journal-title":"Eur Respir J"},{"key":"R28-4-20210206","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/COPD.S2463","article-title":"Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD","volume":"3","author":"Tunnel","year":"2008","journal-title":"Int J COPD"},{"key":"R29-4-20210206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A long-term evaluation of once-daily inhaled tiotorpium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"Eur Respir J"},{"key":"R30-4-20210206","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thorax.58.5.399","article-title":"Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD","volume":"58","author":"Brusasco","year":"2003","journal-title":"Thorax"},{"key":"R31-4-20210206","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"Eur Respir J"},{"key":"R32-4-20210206","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/15412550903156333","article-title":"Combination of formoterol and tiotropium in the treatment of COPD","volume":"6","author":"Cazzola","year":"2009","journal-title":"J COPD"},{"key":"R33-4-20210206","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.05.00140404","article-title":"Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD","volume":"26","author":"van Noord","year":"2005","journal-title":"Eur Respir J"},{"key":"R34-4-20210206","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.129.3.509","article-title":"Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD","volume":"129","author":"van Noord","year":"2006","journal-title":"Chest"},{"key":"R35-4-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15412550902724073","article-title":"Formoterol and tiotropium compared with tiotropium for COPD","volume":"6","author":"Tashkin","year":"2009","journal-title":"COPD: J Chronic Obstruct Pulmon Dis"},{"key":"R36-4-20210206","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.rmed.2007.12.019","article-title":"Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial","volume":"102","author":"Tashkin","year":"2008","journal-title":"Respir Med"},{"key":"R37-4-20210206","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.rmed.2008.07.020","article-title":"Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study","volume":"102","author":"Vogelmeier","year":"2008","journal-title":"Respir Med"},{"key":"R38-4-20210206","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.rmed.2008.12.014","article-title":"Effects of arformoterol twice daily, tiotropium once daily and their combination in subjects with COPD","volume":"103","author":"Tashkin","year":"2009","journal-title":"Respir Med"},{"key":"R39-4-20210206","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1378\/chest.07-2138","article-title":"Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD","volume":"134","author":"Rabe","year":"2008","journal-title":"Chest"},{"key":"R40-4-20210206","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-146-8-200704170-00152","article-title":"Tiotropium in combination with placebo, salmeterol or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: randomized trial","volume":"146","author":"Aaron","year":"2007","journal-title":"Ann Intern Med"},{"key":"R41-4-20210206","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/thx.2007.087213","article-title":"Superiority of \u2018triple\u2019 therapy with salmeterol\/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD","volume":"63","author":"Singh","year":"2008","journal-title":"Thorax"},{"key":"R42-4-20210206","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","article-title":"Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. A systematic review and meta-analysis","volume":"300","author":"Singh","year":"2008","journal-title":"J Am Med Assoc"},{"key":"R46-4-20210206","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/archinternmed.2009.233","article-title":"Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease","volume":"169","author":"Lee","year":"2009","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"R47-4-20210206","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/jam.1999.12.Suppl_1.S-19","article-title":"Optimizing the in vitro performance of Respimat\u00ae","volume":"12","author":"Zierenberg","year":"1999","journal-title":"J Aerosol Med"},{"key":"R48-4-20210206","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/jam.2005.18.273","article-title":"Comparison if the aerosol velocity and spray duration of Respimat\u00ae Soft Mist\u2122 Inhaler and pressurized metered dose inhalers","volume":"18","author":"Hochrainer","year":"2005","journal-title":"J Aerosol Med"},{"key":"R49-4-20210206","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1021\/js950522q","article-title":"Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer","volume":"85","author":"Newman","year":"1996","journal-title":"J Pharm Sci"},{"key":"R50-4-20210206","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/jam.2005.18.264","article-title":"Deposition of corticosteroids aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler","volume":"18","author":"Pitcairn","year":"2005","journal-title":"J Aerosol Med"},{"key":"R51-4-20210206","first-page":"559","article-title":"A dose-ranging study of tiotropium delivered via Respimat\u00ae Soft Mist\u2122 Inhaler or Handihaler\u00ae in COPD patients","volume":"2","author":"Caillard","year":"2007","journal-title":"Int J COPD"},{"key":"R52-4-20210206","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.rmed.2007.08.009","article-title":"T, Lapidus R, Maleki-Yazdi, et al. A randomized study of tiotropium Respimat Soft Mist Inhaler Respimat Soft Mist Inhaler vs. ipratropium pMDI in COPD.","volume":"102","year":"2008","journal-title":"Respir Med"},{"key":"R53-4-20210206","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/bjp.2008.284","article-title":"Novel long-acting bronchodilators for COPD and asthma","volume":"155","author":"Cazzola","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R54-4-20210206","first-page":"482","article-title":"Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD","volume":"10","author":"Cazzola","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"R55-4-20210206","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5414\/CPP47460","article-title":"Safety and pharmacokinetics of single doses of aclidiniium bromide, a novel long-acting antimuscarinic in healthy subjects","volume":"47","author":"Jansat","year":"2009","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Current Opinion in Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCP.0b013e328335df1e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:12Z","timestamp":1786040292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00063198-201003000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mcp.0b013e328335df1e","relation":{},"ISSN":["1070-5287"],"issn-type":[{"value":"1070-5287","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}